BBLGW — Bone Biologics Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1419554 ·
Last close
$10.00
Market Cap
—
52W High
$19.99
52W Low
$6.80
ADV30
473
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -805,054 | -765,988 | 4,979,305 | 4,530,040 | 309,386 |
| Dec 2025 | 0 | — | -733,105 | -684,643 | 5,796,135 | 5,334,322 | 418,587 |
| Sep 2025 | 0 | — | -715,274 | -666,737 | 6,350,799 | 6,049,084 | 334,282 |
| Jun 2025 | 0 | — | -748,075 | -740,519 | 7,002,216 | 6,640,468 | 406,142 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,569,307
Investing CF
—
Financing CF
$4,352,792
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-88,896,357
Inventory
—
Receivables
$7,809
ST Investments
—
EBIT TTM
$-3,001,508
Pretax Income TTM
$-2,857,887
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -3,234,942 | -3,108,991 | 5,796,135 | 418,587 | — | -2,691,150 |
| Dec 2024 | 0 | -4,219,161 | -4,112,420 | 3,861,369 | 377,712 | — | -4,124,935 |
| Dec 2023 | 0 | -9,428,303 | -8,948,731 | 3,737,763 | 831,402 | — | -9,555,904 |
| Dec 2022 | 0 | -3,665,173 | -1,484,620 | 8,495,237 | 2,547,929 | — | -3,566,913 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | $126.59B | $353.33 | — |
| SYK | STRYKER CORP | $124.86B | $325.70 | — |
| MDT | Medtronic plc | $109.30B | $85.39 | — |
| MMM | 3M CO | $90.91B | $176.28 | — |
| BSX | BOSTON SCIENTIFIC CORP | $69.46B | $46.73 | — |
News headlines (Yahoo Finance, 1h cache)
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
2026-07-23 12:00 · Yahoo
BBLG Secures Financing for Critical Trials
2026-07-08 12:15 · Yahoo
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
2026-07-08 00:00 · Yahoo
BBLG In Good Shape as Critical Tests Underway
2026-05-15 12:29 · Yahoo
BBLG Approaching Crucial Stage
2026-02-25 11:06 · Yahoo
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
2026-01-08 13:00 · Yahoo
BC-Most Active Stocks
2025-09-04 14:30 · Yahoo
BBLG Has Solid Balance Sheet as Tests Progress
2025-08-15 11:25 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.